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INTRODUCTION
Psychological research on malignant mesothelioma 
(MM) has shown that its diagnosis has high psychic 
costs for both patients and caregivers. After the diag-
nosis, in fact, both patients and families undergo sig-
nificant changes, and their mental life seems to narrow 
and to focus only on the disease, acknowledgement of 
it, and its negative consequences [1, 2], with significant 
impairment of their quality of life [3-5]. Their mental 
life seems to be characterized by the severe presence 
of anxiety and depression, together with overwhelming 
negative affect (i.e., fears, helplessness, guilt, and rage) 
[3, 4, 6-8].
Moreover, research has also stressed the impact of 
MM in social interactions. One of the major conse-
quences MM patients and their families have to face 
is the redefinition of internal and external roles, taking 
on responsibilities that would previously have been un-
usual, and changing plans because of reduced time left 
to live together and the substantial costs of treatments 
and legal fees [9]. Again, patients and caregivers seem 
to experience intense feelings of exclusion, which may 
compromise their sense of belonging to the community 
and impair social ties, leading to withdrawal [3, 8, 10-
12].
Several national and international guidelines and 
operational recommendations [13-16] underline the 
importance of evaluating the psychological and socio-
relational impact of MM in order to better understand 
the needs of MM patients, to offer appropriate support 
services, and to improve the quality of care worldwide. 
Despite the growing interest in the psychological and 
relational facets of the disease, MM still requires fur-
ther psychological research, and our knowledge on 
psychological processes connected to MM is still poor. 
Specifically, the limited number of studies and the het-
erogeneity of nonspecific measures already used in pre-
vious research do not enable collection of homogenous 
data and prevent comparisons among different studies’ 
results. Moreover, the majority of the available studies 
have been conducted using a quantitative approach, 
while the subjective experience of living with this kind 
of work-related fatal disease seem to be rarely taken 
into account in the literature (for a qualitative literature 
review, see [17]).
In line with the previous considerations, in this paper, 
we would like to present the results of two research lines 
of the Research-Intervention Group of the Department 
of Psychology, University of Turin, “Psychological as-
sessment and whole patient care for malignant meso-
thelioma patients and their caregivers” (for the whole 
research program, see www.dippsicologia.unito.it/do/
gruppi.pl/Show?_id=4ax2):
development of specific measures to detect psycho-
logical distress and needs related to MM;
assessment of the psychological impact of MM diag-
nosis on patients and families.
In the first study, we will present the results of a sys-
tematic literature review aimed at identifying the main 
areas of psychological distress in MM patients, which 
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Abstract
The purpose of this paper is to present two studies. Study 1 is a literature review on 
psychological needs of malignant mesothelioma (MM) patients. Study 2 is aimed at as-
sessing how patients and caregiver experience the diagnosis. In study 1 we performed a 
systematic literature review; while in study 2 we performed a thematic analysis of semi-
structured interviews. Study 1 detected 5 psychological constructs (i.e. 1. Psychological 
impact of MM diagnosis; 2. Emotional aspects connected to the occupational context; 
3. Coping strategies; 4. Treatment experiences; 5. Quality of life). Study 2 identified 4 
themes (i.e. 1. Physical symptoms, affects, and defenses; 2. Living in or near a National 
Priority Contaminated Site; 3. “Nothing is like it was”; 4. “What will become of us?”). The 
literature review suggests a specific profile of suffering for MM, a result strengthened by 
the qualitative study on semi-structured interviews. The present paper highlights the lack 
of specific measures and clinical interventions for this distinctive population.
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will constitute the theoretical basis for the development 
of a specific questionnaire for the assessment of the 
psychological impact of the disease.
In the second study, we will investigate the impact of 
the MM diagnosis through a qualitative bottom-up ap-
proach applied to the verbatim transcriptions of audio-
recorded interviews conducted with MM patients and 
their first-degree caregivers.
STUDY 1: DEVELOPMENT OF SPECIFIC 
TOOLS FOR THE ASSESSMENT  
OF THE PSYCHOLOGICAL IMPACT OF MM
MATERIAL AND METHODS
This study is part of the agreement between the De-
partment of Translational Medicine, University of the 
Oriental Piedmont, and the Department of Psychol-
ogy, University of Turin, for the realization of the proj-
ect “Access to care, psychological support and epide-
miological surveillance of asbestos-related pathologies 
in Italy: an integrated project,” research program 9, 
“Special Program for Asbestos,” ID 59/2016, Call for 
research in cooperation – Plan of research activities 
2016-2018.
Search strategies
A systematic search strategy was used to identify rel-
evant studies. Research included studies published in 
the last 36 years (January 1980-October 2016). Studies 
were identified by searching the following the electronic 
databases: Cochrane Library, Psychology Behavioral 
Sciences Collection, PsychINFO, PubMed, PubGet, 
PubPsych, and Scopus. We used a combination of the 
keywords “mesothelioma” or “asbestos + surveillance” 
or “asbestos + exposed” with “patient”, “experience”, 
“psychological”, “support”, “quality of life”, “stress”, 
“counseling/counselling”, “palliative care”, “psycho-on-
cology”, “depression”, or “anxiety”. 
Any discrepancy regarding the inclusion/exclusion of 
articles was discussed within the research group until an 
agreement was reached. Each potentially relevant study 
selected was obtained in full text and assessed for inclu-
sion in the review independently by four judges. In case 
of disagreement, a fifth judge was consulted.
A standardized data extraction form was used to col-
lect data from each relevant study. Extracted informa-
tion included: 
1.  general study details (authors, year of publication, 
type of study); 
2.  setting (country, industry subsector, and trade and 
job); 
3.  participant details (sociodemographic characteris-
tics); 
4.  type of asbestos exposure (occupational, environ-
mental, familial, leisure activities); 
5.  psychometric tools used;
6.  major outcomes. 
Selection criteria
The systematic review was conducted in accordance 
with the PRISMA – Preferred Reporting Items for Sys-
tematic Reviews and Meta-Analyses – guidelines for 
search, systematization, and report of systematic re-
views [18].
Inclusion criteria were:
1.  quantitative (cohort, case-control, cross-sectional) 
or qualitative (case crossover, case report) studies; 
2.  a population consisting of or including MM patients 
or asbestos-exposed subjects (i.e. people living in as-
bestos contaminated sites) (n > 5); 
3.  focus on the psychological aspects;
4.  only Italian, English, French, or Spanish language;
5.  publication within the given time interval (January 
1980-October 2016).
Exclusion criteria were:
1.  studies conducted on animals or environmental ma-
trices; 
2.  studies not reporting original results (reviews, letters, 
editorials, and comments). 
The entire procedure is displayed in Figure 1.
RESULTS
The selection procedure resulted in an outcome of 
20 articles, 12 on patients and 8 on exposure. Because 
the main aim of the present study is to investigate MM 
patients’ experience, we will consider only the 12 identi-
fied papers on MM patients (for the whole process and 
results, including the ones on exposure to asbestos, see 
[19]). 
Areas investigated by the 12 articles detected are 
summarized below (Table 1).
1. Psychological impact of MM diagnosis on 
individuals 
Several studies focused on the onset of psychologi-
cal reactions to the severe physical conditions of the 
disease. The diagnosis seems to produce a “shock reac-
tion” [6, 20, 21], leading to the development of anxiety, 
depression, apathy, discomfort, difficulties in concen-
tration, and social dysfunctions in the first subsequent 
months [3, 4, 6, 21-23]. The uncertainty about the dis-
ease, along with the awareness of its rapid progression 
and its incurable nature, generate intense anxiety [6], 
compromising social roles and mental well-being [3, 4, 
21]. 
2. Emotional aspects related to the occupational 
context 
The main emotional aspects related to the occupa-
tional context are feelings of being unlucky and disbe-
lief. The long latency period between the exposure and 
the onset of the disease, the sense of belonging to the 
company, the feelings of loyalty toward employers, and 
the legal matters seem to convey intense anger toward 
the family and the physicians [3, 20, 22, 24]. Finally, 
the fear of indirect household exposure and therefore of 
being responsible for unintentional familial contamina-
tion arises [6].
3. Coping strategies 
The main coping mechanisms adopted by patients 
to deal with the negative feelings arising after the MM 
diagnosis are avoidance and denial [6, 22, 24]. Some 
patients seem to adopt optimistic behaviors aimed at 
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restoring a sense of self-efficacy and regaining an active 
role in the management of the disease [20]. Kao and 
colleagues [5] explained the phenomenon of “sickness 
behavior,” used to describe a constellation of nonspe-
cific symptoms such as fatigue, anorexia, fever, depres-
sion, cognitive impairment, and exaggerated response 
to pain, as a maladaptive coping strategy to face the 
impact of the disease.
4. Treatment experiences 
Although subjective experience of treatment varies 
according to the individual physical and psychological 
conditions, the most frequently reported reactions are 
pain and discomfort. Medical treatments (i.e., chemo-
therapy, surgery, radiotherapy) are experienced with 
acute emotional distress, and patients seem to consider 
themselves unable to deal with them [6, 20, 25]. More-
over, health care protocols seem to be linked with feel-
ings of uncertainty and distrust [6]. 
5. Factors affecting the quality of life 
Complementary and alternative medicine, palliative 
and physiotherapy care, and the observance of a spe-
cific diet may increase patients’ sense of control over the 
disease, fostering the idea of having a positive impact 
on it. Furthermore, correct information regarding legal 
aspects of possible compensation seem to increase pa-
tients’ feelings of agency [6, 26]. Finally, support groups 
could play a pivotal role in helping patients manage neg-
ative emotions and reactions connected with MM [27]. 
STUDY 2: ASSESSMENT  
OF THE PSYCHOLOGICAL IMPACT OF MM 
ON PATIENTS AND FAMILIES
MATERIAL AND METHODS
This study is part of the AVPM Project (Assessment 
delle Variabili Psicologiche nei casi di Mesotelioma − 
Assessing Psychological Variables in Mesothelioma), 
12 474 records found 
by searching electronic databases;
11 758 on patients and 
716 on people exposed to asbestos
(i.e. living in CSs)
5634 records after duplicates removed;
5501 on patients and 
133 on people exposed
79 full-text articles assessed;
58 on patients and 21 on people exposed
20 articles were included in qualitative synthesis;
12 patients on and 8 on people exposed
59 full-text articles were excluded
because they were either 
(a) reviews or editorials, or 
(b) did not discuss psychological aspects 
in an adequate manner
5555 articles were excluded because they were either 
(a) written in a language other than Italian,
English, French, or Spanish; 
(b) did not focus onmesothelioma
or asbestos exposure; or 
(c) were experimental in nature and/or focused 
on animals
No additional records
were identied
through other sources
Figure 1
Flow chart of the search strategy and selection procedure.
Table 1
Areas investigated by the 12 articles detected by the system-
atic review
Areas of investigation for the patients N. articles
Psychological impact of MM diagnosis 7
Emotional aspects connected to the occupational 
context
5
Coping strategies 5
Treatment experiences 3
Quality of life 3
1. Psychological impact of MM diagnosis = psychological symptoms and 
emotional responses related with MM physical conditions; 2. Emotional 
aspects connected to the occupational context = emotional distress and 
employer’s psychological reactions related with diagnosis, and occupational 
context; 3. Coping strategies = mechanisms adopted by patients to cope with 
the negative affectivity and emotional distress subsequent to MM diagnosis; 
4. Treatment experiences = subjective experience and emotions related with 
medical treatments; 5. Quality of life = factors affecting the quality of MM 
patient’s life.
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which involves the National Health Center for Asbes-
tos, the Interdepartmental Functional Unit for Ma-
lignant Mesothelioma (UFIM) of the SS. Antonio e 
Biagio e Cesare Arrigo and Santo Spirito Hospitals, 
and the Post-Graduate School in Clinical Psychology 
(SSPC) of the University of Turin (CCM protocol num-
ber J19E12001060001). 
To investigate the subjective impact of MM diagnosis 
on both patients and caregivers, we used a qualitative 
thematic analysis of audio-recorded interviews. Semi-
structured interviews have already been used in previ-
ous research with MM patients [6, 20, 22, 24, 26, 28] 
and allow a more in-depth investigation of the subjec-
tive way of experiencing the disease.
Patients and their first-degree caregivers were admin-
istered semi-structured interviews on specific areas of 
MM experience:
1.  asbestos exposure and work history;
2.  treatment history;
3.  subjective impact of the disease on the individuals 
and on their relationships, particularly family ones;
4.  strategies to deal with end of life, death, and survival.
Interviews were carried out by two trained clinical psy-
chologists, audio recorded, and then independently cod-
ed following Braun and Clarke’s six-step method [29] by 
three of the authors (IGF, FG, and MB). In line with 
the original method, we decided not to quantify quali-
tative data. An inductive data-driven form of thematic 
analysis was adopted: a bottom-up approach in which 
collected data informed theoretical considerations [30].
Participants were recruited and interviewed between 
October 2014 and January 2015, and November 2016 
and October 2017 at the UFIM, as a preliminary step 
for the recruitment of participants for the brief psy-
chodynamic group interventions structured by our Re-
search-Intervention Group. The recruitment process is 
still ongoing, and the next interviews will be carried out 
between February and March 2018.
Inclusion criteria were:
1.  having a diagnosis of MM in any localization or be-
ing a family member/caregiver;
2.  MM diagnosis < 6 months;
3.  signing an informed written consent form.
Exclusion criteria were:
1.  having poor knowledge of the Italian language;
2.  having a certified psychiatric diagnosis;
3.  having a certified diagnosis of a neurodegenerative 
disease (e.g., Alzheimer’s disease, Parkinson’s dis-
ease, etc.).
All subjects participated anonymously in the study 
and gave their informed written consent. The AVPM 
Project, including the present study, was approved by 
the local Institutional Review Board (IRB) and the 
Hospital Ethical Committee (AVPM-14/11/2014) and 
was conducted in accordance with the Declaration of 
Helsinki. All participants’ names have been disguised 
to protect confidentiality.
Participants
During the recruitment period, 131 new diagnoses of 
MM occurred, consistent with the epidemiological data 
of Casale Monferrato [31]. Eleven (8.40%) subjects 
were excluded because of their critical clinical condi-
tions, 36 (27.48%) only had their first visit at the UFIM, 
36 (27.48%) stated that they were not interested in the 
interviews, 11 (8.40%) decided not to participate in the 
interviews because they lived far from the UFIM, and 4 
(3.05%) were excluded because of their psychological/
psychiatric conditions.
The final sample (N = 61) is composed of 33 MM 
patients (54.09%) and 28 caregivers (45.90%). Table 2 
shows the sociodemographic and clinical characteristics 
of the sample, differentiated for clinical condition (pa-
tients/caregivers).
RESULTS
The thematic analysis identified four different themes:
1.  physical symptoms, affects, and defenses;
2.  living in or near a National Priority Contaminated 
Site (NPCS);
3.  “Nothing is like it was”;
4.  “What will become of us?” (Figure 2).
1. Physical symptoms, affects, and defenses
1a. Facing new limitations/needs
The impact of the disease leads to invalidating symp-
toms and a new physical condition that require both 
patients and caregivers to come to terms with emerg-
ing needs connected to a sick body, undergoing severe 
medical treatments – even experimental ones.
Fabrizia (caregiver): In ten days, let’s say, our lives, 
and most of all her [her mother, who has MM] life, 
turned upside down.
Kate (patient): I’m very, very angry. But not…not 
because of the disease in itself, because I was used to 
doing everything, all alone.
Giusy (caregiver): She [her mother-in-law, who has 
MM] used to be autonomous, completely, to help the 
others. […] This has been really hamstringing for her.
During the interview process, a large number of 
patients (26/33) were involved in clinical trials at the 
UFIM, causing them to feel like “guinea pigs”.
Clara (patient): Let’s see, we’ll see. We’ll get to see 
where those treatments will take us. I’m like a guinea 
pig, we’ll see. Maybe, well, we’ll carry this on, I don’t 
know, because it’s a clinical trial.
At the same time, for some patients and caregivers, 
clinical trials seemed to be the only and best way to be 
treated for MM.
Adriana (patient): The doctor wanted to suspend 
his [another patient’s] experimental treatment, inter-
rupt it, but he doesn’t agree, because he thinks that 
he will not be followed anymore for his disease and his 
treatments.
1b. Affects connected to the disease
Thinking about the disease gives rise to many painful 
consequences, such as rage and depressive symptoms, 
linked with the perception of one’s own finitude and 
mortality.
Luigi (patient): There are times when you just, uh, 
you just mope around up.
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Antonio (caregiver): We’re all upset.
Maria Pia (patient): My whole world has fallen 
apart. […] When the ultimate diagnosis arrived, it killed 
me, in a moment. […] I’ve been killed that day.
Giuliana (patient): I am afraid of blowing up.
Silvia (caregiver): I thought she [her mother, who 
has MM] was immortal.
1c. Death and aerial contagion phantasies
The fear of an “aerial contagion” of the disease could 
be traced in many participants’ words, as well as ubiq-
uitous death anxieties and a sort of “phantom of death” 
that could strike everybody, even the strongest ones. 
Mirella (caregiver): I mean, he [her husband, who 
has MM] doesn’t have the leprosy.
Table 2
Sociodemographic and clinical characteristics of the sample
Full sample (N = 61) Patients (N = 33) Caregivers (N = 28)
M SD Range M SD M SD t-test p-value
Age 60.08 12.10 22-77 64.76 8.16 54.57 13.73 -3.585 0.001
N % n % n % χ2 gdl p-value
Gender 10.94 1 0.001
Males 27 44.30 21 63.64 6 21.43
Females 34 55.70 12 36.36 22 78.57
Educational Level 6.22 4 0.183
Elementary School 7 11.50 5 15.15 2 7.14
Middle School 20 32.80 14 42.42 6 21.42
High School 25 41.00 9 27.27 16 57.12
Degree 7 11.50 4 12.12 3 10.71
Post-Degree 2 3.30 1 3.03 1 3.57
Work 7.75 8 0.458
Employee 18 29.50 9 27.27 9 32.13
Teachers 4 6.60 2 6.06 2 7.14
Laborer 7 11.50 4 12.12 3 10.71
Freelance professional 8 13.10 5 15.15 3 10.71
Health professional 1 1.60 0 0 1 3.57
Legal professional 5 8.20 2 6.06 3 10.71
Artist 1 1.60 0 0 1 3.57
Housewife 2 3.30 0 0 2 7.14
Retired 15 24.60 11 33.33 4 14.28
Family Status 4.47 5 0.484
Single 1 1.60 0 0 1 3.57
Cohabitants 2 3.30 1 3.03 1 3.57
Married 49 80.30 26 78.78 23 82.11
Separated 3 4.90 2 6.06 1 3.57
Divorced 3 4.90 3 9.09 0 0
Widow 3 4.90 1 3.03 2 7.14
Diagnosis
epithelioid pleural 
mesothelioma
23 69.69
sarcomatoid pleural 
mesothelioma
1 3.03
biphasic pleural 
mesothelioma
8 24.24
peritoneal 
mesothelioma
1 3.03
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Gabriella (caregiver): And there was a lady back in 
those days, in that very week when I went there, there 
was a lady who passed away that very morning. […]. She 
was a lady I knew, she had the strongest body that lady.
1d. Denial of painful emotions and strategies of avoidance/
withdrawal
From the participants’ narratives arose avoidant at-
titudes toward the emotional burden connected to the 
MM prognosis, showing the internalization of an inter-
nal logic based on not thinking/not seeing.
Mauro (caregiver): You try not to think about it. 
The less I think about it, the better I feel.
Bruno (patient): [another patient] told me: “Why 
are you so low? You don’t have to think about that. I 
never think about that.”
Laura (caregiver): I don’t know if you really want 
to be aware of it, because you see her [her mother, who 
has MM] feeling good in this moment and you try to do 
what you’ve always done.
Many patients and caregivers seem to fight against 
feelings of guilt and shame connected to their illness. 
Gazes and questions activate intense feelings difficult 
to metabolize, which the patients seem to face with a 
withdrawal attitude. 
Anna Rita (caregiver): There’s nothing to be 
ashamed of, huh. I think. Because there are people who 
really […] don’t talk about that, you know. […] What do 
you want to hide anyway?
Rino (patient): [and they ask you]: “How are you 
doing?” How do you think I’m doing? Don’t be a pain 
in the ass!
Luca (patient): I’ve started thinking […] “Now I’ll 
go around, they’ll see soon that I have mesothelioma, 
that I have a disease.” And then I’ve asked to myself: 
“But why they have to see it? I don’t have it written on 
my face.”
Elvira (caregiver): It’s like living as rats hiding in 
the hole.
2. Living in or near an NPCS
2a. Awareness of the increased health risk
During the interviews, all the subjects talked about 
the etiology of MM, connecting it with the geographical 
area in which they used to reside. They were all aware 
that living in or near Casale Monferrato represented a 
high risk for developing MM since their childhood and 
that it could still represent a risk for their health and the 
health of their loved ones.
Clara (patient): It’s something that just happened, 
it happens to anyone [here], it could happen to anyone.
Physical symptoms,
affects and defenses “Nothing is like it was”
Trapped into present
vs forward-looking
Aggressiveness-withdrawal
circuit
Difficulties in openly
talking about the disease
and the future
Worries
for the beloved ones
Affects connected
to the disease
Facing new
limitations/needs
Death and aerial
contagion phantasies
Denial of painful emotions
and strategies
of avoidance/withdrawal
“What will become of us?”
Summing up one’s life
Need for sharing
and support
Awareness of the
 increased health risk
Living in/near a NPCS
Damage and
compensation
Figure 2
Thematic map.
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Matteo (patient): It happened to me, but it could 
happen to anybody here, after all, look. This not to be 
fatalistic, but how many ones we have left behind, even 
younger than me.
2b. Need for support and sharing 
Some patients and caregivers put into words their 
need for affective closeness, containment, and the pos-
sibility to share the painful facets of the disease. In the 
narratives, the struggle to make sense of the diagno-
sis and its consequences with the loved ones strongly 
emerged.
Marta (caregiver): I count very much on […] the 
possibility that he [the husband, who has MM] can 
compare himself to others with the same disease. So 
that he can stop feeling as he was marked by God. 
Because he says very often: “Why is this happening to 
me?” 
Salvatore (patient): I don’t have a companion. At 
night, I find myself all alone. You cannot say: “I have 
someone to whom I can talk about that”. Yea, there is 
my son and my ex-wife, perhaps they will ask me how 
am I doing.
Filippo (patient): The point is always this: all you 
need is having the guts to say the first line, to talk, to 
communicate with the others, rightly, because if you 
stay in silence it’s obvious that it’s always hard to com-
municate.
Vittorio (caregiver): She was on the ground, but 
that day, let’s say, talking with [another patient] she 
is reborn. They cheered her up, in a word, with their 
words.
2c. Damage and compensation
More than half of the sample talked about the trial 
against the Eternit factory and expressed a strong feel-
ing of injustice, together with retaliation for the suf-
fered damage.
Rino (patient): To attest that it is an occupational 
disease, I had to go to the INAIL and take some wit-
nesses. They went there and answer all their questions 
[…]. They make it harder so that they don’t have to pay: 
after all, it’s mesothelioma. You should have the right 
and stop.
Loredana (patient): A lot of people really feel these 
feelings of shame, but in my opinion it’s not mine, the 
shame. The shame is in the social world, that has not 
promptly intervened to stop some these things. Namely, 
I am the victim, there is no reason to be ashamed of 
being a victim.
3. “Nothing is like it was”
3a. Trapped in the present vs forward-looking
Patients focused on how their lives had changed be-
cause of MM, sometimes minimizing the impact of the 
diagnosis, sometimes putting emphasis on making the 
best use of the time left, sometimes talking about small 
goals they desired to reach and things they would like to 
do. Narratives show a constant tension between being 
stuck in a present worsened by the disease and the pos-
sibility of having a forward gaze to the future.
Fabio (patient): Well, nothing is like it was. You 
have to think about your situation and make it go on 
in another way.
Sofia (patient): Indeed, these are the things that 
give you the chance to see the world not all black, but 
pale rose.
Camilla (patient): Sometimes I think about it, I 
even start crying alone. Others, I try not to think about 
that, I try to find ways to get distracted in any way, to 
give space to the things that I love, to the dreams that I 
still have. Dreams are not forbidden.
3b. Aggressiveness-withdrawal circuit
Caregivers showed a tendency to aggressively under-
line that their relatives changed after the MM diagno-
sis, grumbling against them and complaining that they 
were no longer as they used to be (desire vs reality).
Elvira (caregiver): […] Why isn’t he playing [the 
saxophone] anymore? Why is he behaving like that? 
Why doesn’t he have these things [he used to do]?
Luisa (caregiver): They have always told him that 
he can live a normal life. He is the one who refuses 
to do so. […] He could live a very normal life, but he 
doesn’t, because he knows he is sick. […] It makes me 
even madder that I cannot convince him to have a nor-
mal life.
Sometimes the patients themselves underline their 
changes and try to ward off their loved ones so that they 
cannot see how they have changed and will change be-
cause of the disease.
Maria Pia (patient): He wants to stay close to me, 
but it’s hard, very hard for me, because I’ve changed. 
I’m angry, mean, I do not bear anybody anymore, I 
don’t want to see anybody. And I feel, I don’t know, a 
nullity. […] I’ve told him: “Let’s finish here our relation-
ship”. But he does not want to.
Such communications create a big emotional dis-
tance, triggering a circuit of aggressiveness and with-
drawal that strongly impairs the quality of family ex-
changes.
Bruno (patient): She hurts herself and she becomes 
annoying with me.
Rosangela (patient): It’s not that I don’t want to 
fight or that they bother me. Well, but I’m saying that 
they always poke me.
4. “What will become of us?”
4a. Worries for the loved ones
Patients more often than caregivers expressed worries 
about the impact of MM on their families and about 
the fate of their loved ones.
Elisa (patient): Well, I think I can handle it, but 
what about him [the husband, MM patient]?
Domenico (patient): When I discovered it, there 
was a week, ten days, when I said: “Oh, jeez, what do 
I do? What will become of my future?” This is the first 
thing you start thinking of, not so much for me and for 
my fear, but for my children.
Angelo (patient): At first I was the one who sup-
ported her [the wife] and not she who supported me. 
Oh, well, I told her: “Take it easy. I do not give up”.
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4b. Difficulties in openly talking about the disease and the 
future
Participants’ narratives show a certain difficulty in 
openly talking about the illness, their/their loved one’s 
death, and the future, combined with an implicit de-
mand to find new ways to talk about that in their fami-
lies.
Rosangela (patient): He [the husband, MM pa-
tient] doesn’t want to talk about my disease. […] He 
doesn’t talk with anybody.
Mirella (caregiver): Maybe [talking] in one way or 
another you can exchange views and ways to manage all 
of these, that could be completely different.
4c. Summing up one’s life
For many patients, the diagnosis became a way to 
start thinking about their lives and how they have lived 
them.
Rosalinda (patient): This does not worry us, at all. 
We have worked, we have worked the entire life and 
then we have also built things. We are happy about that.
Loredana (patient): Look, it’s a work you have to 
do. I hope I’ve walked well in my life, to have spent it 
well and that’s it. If [the treatments] will go well, I am 
really happy, because I still have some ambitions to real-
ize. If it will go bad, it doesn’t matter.
DISCUSSION
The main aim of the present paper was to offer an 
overview of two research lines of the Research-Inter-
vention Group of the Department of Psychology, Uni-
versity of Turin, “Psychological assessment and whole 
patient care for malignant mesothelioma patients and 
their caregivers”.
Because there are no homogenous data and due to 
the absence of specific tools for the assessment of the 
psychological impact of MM, at the beginning of the 
paper, we presented the results of a systematic litera-
ture review (study 1: Development of specific question-
naires to detect the psychological distress and needs 
connected with MM). The review process led to the 
identification of 5 main areas of psychological distress 
connected with MM (psychological impact of MM 
diagnosis; emotional aspects connected to the occu-
pational context; coping strategies; feeling connected 
to the treatment experience; quality of life), which will 
constitute the theoretical basis for the construction of a 
brief self-reported specific questionnaire.
The systematic review highlights that MM diagnosis 
is a traumatic event strictly connected with the occu-
pational milieu of the disease, the reduced efficacy of 
medical treatments, and the poor prognosis. It has been 
suggested that the lack of effective treatments and de-
fined guidelines may lead MM patients to experience 
feelings of confusion and uncertainty with respect to 
what is going to happen in their treatments and in their 
whole lives [20, 28]. Moreover, the awareness of the 
work-related etiology of the disease leads to specific 
forms of emotional distress, including rage and shame 
due to the unfair fate (i.e., becoming ill because of their 
work), along with feelings of guilt and a sense of re-
sponsibility for the onset of the disease and for having 
exposed their loved ones to increased health risk [29, 
32]. These negative emotions are painful and difficult to 
elaborate on, and MM patients may experience an in-
ternal conflict related with their sense of belonging and 
loyalty to the company/factory and their occupational 
identity. To face negative affectivity, patients often acti-
vate avoidance and denial strategies, which allow them 
to survive the catastrophic impact of the diagnosis by 
splitting the emotions connected to the disease and 
minimizing its impact [10].
One important result emerging from the review is the 
patients’ subjective view of treatments, which seem to 
be experienced with a certain lack of trust and discom-
fort, probably because of the uncertainty of their effec-
tiveness. Arber and Spencer [6] underlined that the un-
predictable and rapid onset of MM may generate acute 
emotional distress in patients and compromise their 
efforts to deal with it, shaking down their faith in the 
health care protocols they are involved with. Moreover, 
patients enrolled in experimental clinical trials may ex-
perience intense conflicting emotions about the treat-
ments: the fear of having a placebo may lead them to 
develop an aggressive attitude toward the health institu-
tions that use them as “guinea pigs” and cannot prevent 
them from dying [28].
Finally, the review shed light on the importance of 
complementary and alternative medicine (e.g., pal-
liative care, kinesiotherapy, diet) as well as of the legal 
and psychological facets of the disease, suggesting they 
should also be taken into account in the management 
of MM. Indeed, fostering these aspects may increase 
the active role of patients, increasing their agency and 
fostering the idea of having a positive impact on their 
medical journey and their whole life [33]. Asbestos 
support groups play a pivotal role in the process giving 
correct information about legal issues and the compen-
sation process, as well as helping families affected by 
this work-related cancer to explore and elaborate on the 
negative effects linked with MM. As we suggested else-
where, mesothelioma patient care and treatment should 
include an inter-disciplinary approach, which implies a 
highly specialized medical staff, advising caregivers on 
the correct management of symptoms, providing emo-
tional support to the whole family, and exploring treat-
ment options, as well as legal and financial options [34].
The main themes that emerged from the literature re-
view are supported by the results of the thematic analy-
sis presented in the second part of the paper (study 2: 
Assessment of the psychological impact of MM in pa-
tients and families). In line with previous studies [31], 
patients are more often males, while caregivers are 
more often females and younger. In fact, the majority of 
our sample had occupational exposure to asbestos, and 
a large amount of them worked at the Eternit factory.
The thematic analysis identified four different 
themes: 1. physical symptoms, affects, and defenses; 2. 
living in or near an NPCS; 3. “Nothing is like it was”; 
and 4. “What will become of us?”
The interviews show that MM deeply compromises 
the body and the mind of those affected: indeed, a 
large amount of participants talk about fragilities and 
physical limits, new emerging needs for concrete help, 
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closeness, and affective involvement in such a painful 
time of their life. Guilt, helplessness, anger, and shame 
seem to destabilize both patients and caregivers, and 
to be often hidden in the family communications. The 
suffering connected to the illness seems to be actively 
denied: a sort of “out of sight, out of mind” attitude 
[20] seems to emerge, which prevents complete elabo-
ration of the disease and the grief. Straker [35] pointed 
out that often cancer patients find themselves alone in 
front of the disease and overwhelming death anxieties 
they try to cope with through the activation of primi-
tive defenses (i.e., denial, splitting, omnipotence). The 
activation of these defenses may lead to a sort of “you 
don’t have to think about that” attitude, revealing the 
tendency for denying mortality and avoiding a harmful 
reality [6, 24].
Dealing with MM could be too harsh of a reality to 
face, in particular in an NPCS, characterized by an 
increased health risk for the whole population. Some 
patients feel like some sort of “plague spreaders,” re-
vealing the fear of infecting and being infected. The 
community has undertaken a lot of concrete actions 
to oppose asbestos (i.e., the creation of a park called 
Eternot in the place where the factory used to be as 
a symbol of memory and witness). Nevertheless, the 
community still has a strong idea of a contagion that 
can affect and kill anybody, even long after the factory’s 
closure and the asbestos ban [33, 36]. There is a sort 
of taboo for some of them, as if not talking about MM 
would mean getting away from the idea of separation 
and death [37]. It seems easier for them to speak about 
the damage they have suffered and ask for concrete 
compensation for what was unfairly taken away from 
them [38].
Patients describe caregivers as powerless witnesses of 
their illness. It seems very difficult for the caregivers to 
accept the gap between the mental and physical condi-
tions of their loved ones as they were and as they are 
now, between the life they desire to live together and 
what they can do because of their new limitations (de-
sire vs reality). It could be possible that the frustration 
and the hopelessness connected to the impossibility to 
modify this situation cause the caregivers to aggressive-
ly react to the limitations and the needs of the patients 
in an attempt to push them to actively react to the dis-
ease. However, this communicative strategy gives rise 
in the patients to the feeling of not being recognized 
in their condition and leads to affective and relational 
withdrawal.
Finally, patients and caregivers wonder about their 
future: They seem to be worried more for their loved 
ones than for their own fate. They express difficulty in 
openly talking one to others about what is happening to 
them and what they are feeling [38-40]. This tendency 
could possibly be connected to a sort of unconscious 
attempt to protect others from the devastating impact 
of the disease. The request for new and more adaptive 
communicative modalities between patients and their 
families subtly emerges, which can help find new ways 
to talk about the disease in a sharing and close climate.
CONCLUSIONS
Psychological research on MM has important clinical 
implications for the management of both patients and 
their caregivers. It should be aimed at investigating the 
emotional features of the disease in order to increase 
the understanding of the psychological and relational 
facets of MM. Moreover, we strongly suggest the im-
portance of building bridges between psychological 
research and interventions so that scholars can define 
shared international guidelines and evidence-based 
health care protocols including different disciplines. In 
our opinion, considering the occupational etiology of 
the disease, protocols should also include a strong link 
with unions, associations, and institutions (public or 
private) involved in the legal procedures for the com-
pensation.
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